Analysis of serum levels of cytokines, chemokines, growth factors, and monoamine neurotransmitters in patients with tick-borne encephalitis: Identification of novel inflammatory markers with implications for pathogenesis

Journal of Medical Virology

Volumn 87, Issue 5, 2015, Pages 885-892

  Palus, Martin ^a,b,c   Formanová, Petra ^a,d   Salát, Jiří ^a   Žampachová, Eva ^e   Elsterová, Jana ^a,b,c   Růžek, Daniel ^a,b,c,d  

^a Veterinary Research Institute   (Czech Republic)

^b INSTITUTE OF PARASITOLOGY   (Czech Republic)

^c UNIVERSITY OF SOUTH BOHEMIA   (Czech Republic)

^d MASARYK UNIVERSITY   (Czech Republic)

^e eské Bud jovice Hospital   (Czech Republic)

Author keywords

Luminex; Neuroinfection; Neuroinflammation; Tick borne encephalitis virus

Indexed keywords

CHEMOKINE; CYTOKINE; DOPAMINE; EOTAXIN; GAMMA INTERFERON INDUCIBLE PROTEIN 10; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; GROWTH FACTOR; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 13; INTERLEUKIN 15; INTERLEUKIN 17; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; INTERLEUKIN 7; INTERLEUKIN 8; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MONOAMINE; MONOCYTE CHEMOTACTIC PROTEIN 1; NEUROTRANSMITTER; NORADRENALIN; SCATTER FACTOR; SEROTONIN; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN; AGENTS INTERACTING WITH TRANSMITTER, HORMONE OR DRUG RECEPTORS; BIOGENIC AMINE; SIGNAL PEPTIDE;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CONTROLLED STUDY; DOPAMINE BLOOD LEVEL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NERVOUS SYSTEM INFLAMMATION; NORADRENALIN BLOOD LEVEL; PROTEIN BLOOD LEVEL; SEROTONIN BLOOD LEVEL; TICK BORNE ENCEPHALITIS; VIRUS PATHOGENESIS; BLOOD; CHEMISTRY; IMMUNOASSAY; PATHOLOGY; PRESCHOOL CHILD; SERUM; VERY ELDERLY; YOUNG ADULT;

IXODIDA; TICK-BORNE ENCEPHALITIS VIRUS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BIOGENIC MONOAMINES; CHILD; CHILD, PRESCHOOL; CYTOKINES; ENCEPHALITIS, TICK-BORNE; FEMALE; HUMANS; IMMUNOASSAY; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MIDDLE AGED; NEUROTRANSMITTER AGENTS; SERUM; YOUNG ADULT;

EID: 84925122220     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.24140     Document Type: Article

References (37)

1. Atrasheuskaya AV, Fredeking TM, Ignatyev GM. 2003. Changes in immune parameters and their correction in human cases of tick-borne encephalitis. Clin Exp Immunol 131:148-154.
2. Ay I, Francis JW, Brown RH, Jr. 2008. VEGF increases blood-brain barrier permeability to Evans blue dye and tetanus toxin fragment C but not adeno-associated virus in ALS mice. Brain Res 1234:198-205.
3. Charrel RN, Attoui H, Butenko AM, Clegg JC, Deubel V, Frolova TV, Gould EA, Gritsun TS, Heinz FX, Labuda M, Lashkevich VA, Loktev V, Lundkvist A, Lvov DV, Mandl CW, Niedrig M, Papa A, Petrov VS, Plyusnin A, Randolph S, Süss J, Zlobin VI, de Lamballerie X. 2004. Tick-borne virus diseases of human interest in Europe. Clin Microbiol Infect 10:1040-1055.
4. Cosenza-Nashat M, Zhao ML, Marshall HD, Si Q, Morgello S, Lee SC. 2007. Human immunodeficiency virus infection inhibits granulocyte-macrophage colony-stimulating factor-induced microglial proliferation. J Neurovirol 13:536-548.
5. Dinarello CA. 1998. Interleukin-1, interleukin-1 receptors and interleukin-1 receptor antagonist. Int Rev Immunol 16:457-499.
6. Fenton H, Finch PW, Rubin JS, Rosenberg JM, Taylor WG, Kuo-Leblanc V, Rodriguez-Wolf M, Baird A, Schipper HM, Stopa EG. 1998. Hepatocyte growth factor (HGF/SF) in Alzheimer's disease. Brain Res 779:262-270.
7. Gelpi E, Preusser M, Laggner U, Garzuly F, Holzmann H, Heinz FX, Budka H. 2006. Inflammatory response in human tick-borne encephalitis: Analysis of postmortem brain tissue. J Neurovirol 12:322-327.
8. Giulian D, Ingeman JE. 1988. Colony-stimulating factors as promoters of ameboid microglia. J Neurosci 8:4707-4717.
9. Haglund M, Forsgren M, Lindh G, Lindquist L. 1996. A 10-year follow-up study of tick-borne encephalitis in the Stockholm area and a review of the literature: Need for a vaccination strategy. Scand J Infect Dis 28:217-224.
10. Juchnowicz D, Rudnik I, Czernikiewicz A, Zajkowska J, Pancewicz SA. 2002. [Mental disorders in the course of Lyme borreliosis and tick borne encephalitis]. Przegl Epidemiol 56:37-50.
11. Kang X, Li Y, Wei J, Zhang Y, Bian C, Wang K, Wu X, Hu Y, Li J, Yang Y. 2013. Elevation of matrix metalloproteinase-9 level in cerebrospinal fluid of tick-borne encephalitis patients is associated with IgG extravassation and disease severity. PLoS ONE 8:e77427.
12. Kondrusik M, Pancewicz S, Zajkowska J, Hermanowska-Szpakowicz T. 2001. Tumor necrosis factor alpha and interleukin 1-beta in serum of patients with tick-borne encephalitis. Pol Merkur Lekarski 11:26-28.
13. Kono S, Nagaike M, Matsumoto K, Nakamura T. 1992. Marked induction of hepatocyte growth factor mRNA in intact kidney and spleen in response to injury of distant organs. Biochem Biophys Res Commun 186:991-998.
14. Kouro T, Takatsu K. 2009. IL-5- and eosinophil-mediated inflammation: From discovery to therapy. Int Immunol 21:1303-1309.
15. Lee SC, Liu W, Brosnan CF, Dickson DW. 1994. GM-CSF promotes proliferation of human fetal and adult microglia in primary cultures. Glia 12:309-318.
16. März P, Otten U, Rose-John S. 1999. Neural activities of IL-6-type cytokines often depend on soluble cytokine receptors. Eur J Neurosci 11:2995-3004.
17. Mansfield KL, Johnson N, Phipps LP, Stephenson JR, Fooks AR, Solomon T. 2009. Tick-borne encephalitis virus - A review of an emerging zoonosis. J Gen Virol 90:1781-1794.
18. Matsumoto K, Nakamura T. 1991. Hepatocyte growth factor: Molecular structure and implications for a central role in liver regeneration. J Gastroenterol Hepatol 6:509-519.
19. Mayhan WG. 1999. VEGF increases permeability of the blood-brain barrier via a nitric oxide synthase/cGMP-dependent pathway. Am J Physiol 276:C1148-C1153.
20. Misra UK, Kalita J, Pandey S, Khanna VK, Babu GN. 2005. Cerebrospinal fluid catecholamine levels in Japanese encephalitis patients with movement disorders. Neurochem Res 30:1075-1078.
21. Ozden M, Kalkan A, Demirdag K, Denk A, Kilic SS. 2004. Hepatocyte growth factor (HGF) in patients with hepatitis B and meningitis. J Infect 49:229-235.
22. Palus M, Vojtíšková J, Salát J, Kopecký J, Grubhoffer L, Lipoldová M, Demant P, Růžek D. 2013. Mice with different susceptibility to tick-borne encephalitis virus infection show selective neutralizing antibody response and inflammatory reaction in the central nervous system. J Neuroinflammation 10:77.
23. Palus M, Zampachová E, Elsterová J, Růžek D. 2014. Serum matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 levels in patients with tick-borne encephalitis. J Infect 68:165-169.
24. Raivich G, Gehrmann J, Kreutzberg GW. 1991. Increase of macrophage colony-stimulating factor and granulocyte-macrophage colony-stimulating factor receptors in the regenerating rat facial nucleus. J Neurosci Res 30:682-686.
25. Roberts WG, Palade GE. 1995. Increased microvascular permeability and endothelial fenestration induced by vascular endothelial growth factor. J Cell Sci 108:2369-2379.
26. Růžek D, Dobler G, Donoso Mantke O. 2010. Tick-borne encephalitis: Pathogenesis and clinical implications. Travel Med Infect Dis 8:223-232.
27. Růžek D, Salát J, Palus M, Gritsun TS, Gould EA, Dyková I, Skallová A, Jelínek J, Kopecký J, Grubhoffer L. 2009. CD8+ T-cells mediate immunopathology in tick-borne encephalitis. Virology 384:1-6.
28. Schmolck H, Maritz E, Kletzin I, Korinthenberg R. 2005. Neurologic, neuropsychologic, and electroencephalographic findings after European tick-borne encephalitis in children. J Child Neurol 20:500-508.
29. Sumlivaya ON, Vorobyeva NN, Karakulova YuV. 2013. State of humoral part of the serotonergetic system in patients with tick-borne encephalitis. Abstract. Proceedings of Russian Scientific Conference with International Participation "Up-to-date Problems of Tick-borne Encephalitis." October 8-10, 2013. Chumakov Institute of Poliomyelitis and Viral Encephalitides, Moscow, Russia, p 45.
30. Suss J. 2008. Tick-borne encephalitis in Europe and beyond-the epidemiological situation as of 2007. Euro Surveill 13:18916.
31. Thompson WL, Karpus WJ, Van Eldik LJ. 2008. MCP-1-deficient mice show reduced neuroinflammatory responses and increased peripheral inflammatory responses to peripheral endotoxin insult. J Neuroinflammation 5:35.
32. Toporkova MG, Aleshin SE, Ozherelkov SV, Nadezhdina MV, Stephenson JR, Timofeev AV. 2008. Serum levels of interleukin 6 in recently hospitalized tick-borne encephalitis patients correlate with age, but not with disease outcome. Clin Exp Immunol 152:517-521.
33. Trinchieri G. 2003. Interleukin-12 and the regulation of innate resistance and adaptive immunity. Nat Rev Immunol 3:133-146.
34. Tsuboi Y, Kakimoto K, Akatsu H, Daikuhara Y, Yamada T. 2002. Hepatocyte growth factor in cerebrospinal fluid in neurologic disease. Acta Neurol Scand 106:99-103.
35. Valable S, Montaner J, Bellail A, Berezowski V, Brillault J, Cecchelli R, Divoux D, Mackenzie ET, Bernaudin M, Roussel S, Petit E. 2005. VEGF-induced BBB permeability is associated with an MMP-9 activity increase in cerebral ischemia: Both effects decreased by Ang-1. J Cereb Blood Flow Metab 25:1491-1504.
36. Yamada T, Tsubouchi H, Daikuhara Y, Prat M, Comoglio PM, McGeer PL, McGeer EG. 1994. Immunohistochemistry with antibodies to hepatocyte growth factor and its receptor protein (c-MET) in human brain tissues. Brain Res 637:308-312.
37. Zajkowska J, Moniuszko-Malinowska A, Pancewicz SA, Muszyńska-Mazur A, Kondrusik M, Grygorczuk S, Swierzbińska-Pijanowska R, Dunaj J, Czupryna P. 2011. Evaluation of CXCL10, CXCL11, CXCL12 and CXCL13 chemokines in serum and cerebrospinal fluid in patients with tick borne encephalitis (TBE). Adv Med Sci 56:311-317.